F-star Therapeutics Appoints James Sandy as Chief Development Officer

Go back to F-star Therapeutics Appoints James Sandy as Chief Development Officer
(NASDAQ: FSTX) Delayed: 7.12 --0 (-0%)
Previous Close $7.12    52 Week High $ 
Open $12.36    52 Week Low $ 
Day High $7.12    P/E N/A 
Day Low $7.12    EPS $ 
Volume 1,067,673       

(NASDAQ: IMCR) Delayed: 31.83 +0.55 (1.76%)
Previous Close $31.28    52 Week High $ 
Open $31.22    52 Week Low $ 
Day High $31.93    P/E N/A 
Day Low $31.04    EPS $ 
Volume 160,572